2024-519316-13-00
CTIS ↗
PT00114-001A
Phase I study in healthy male and female volunteers. Intended indication: mood disorders
pharma · PTIX
Protagenic Therapeutics, Inc.new
Protagenic Therapeutics, Inc.new trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
NEW YORK, NY, USA HQ
1 Employees
Public company Type
PTIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- NEW YORK, NY, USA
- Employees
- 1
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Protagenic Therapeutics, Inc.new clinical trials
Registry index of 1 ClinicalTrials.gov studies linked to Protagenic Therapeutics, Inc.new programs — each row shows trial ID, program name, phase, status, and indication.
Protagenic Therapeutics, Inc.new trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Protagenic Therapeutics, Inc.new.